Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Potent and selective progestogens from Theramex

Sep. 26, 1997

Positive efficacy results obtained in phase II trial of ALX1-11; phase III trials will begin soon

Sep. 25, 1997

Crinone approved for marketing in Germany

Sep. 25, 1997

Osteoporosis indication for tiludronate dropped

Sep. 25, 1997

Spotlight on bisphosphonates in osteoporosis

Sep. 25, 1997

Novo Nordisk presents potassium channel openers/blockers

Sep. 25, 1997

Study results of Crinone as ART treatment presented

Sep. 24, 1997

Acute vasodilating effects of KDI-792 in diabetics

Sep. 23, 1997

Clinical trials begin with topical impotence treatment

Sep. 23, 1997

BM-41.0904: a potential new osteoanabolic agent

Sep. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...